Transforming Obesity Treatment with Precision Medicine with Mark Bagnall, CEO of Phenomix Sciences
Audio is streamed directly from the publisher (pfx.vpixl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Struggles with obesity can be transformed with a precision medicine approach.
In this episode, Mark Bagnall, CEO of Phenomix Sciences, shares his expertise in using precision medicine to tackle obesity. He highlights the limitations of viewing obesity as a uniform disease and the importance of understanding individual biomarkers for personalized treatments. Mark introduces "my Phenome," a saliva-based test that identifies obesity phenotypes and best treatment options, saving costs and avoiding side effects of GLP-1 drugs. He also stresses the responsible use of GLP-1 drugs and highlights alternatives like Qsymia. The company's precision approach, enabled by advanced AI technology, has garnered significant interest, signaling a transformative shift in obesity treatment.
Tune in and learn how precision medicine is paving the way for more personalized and effective obesity treatments!